BioScience Health Innovations (BHIC) Equity Ratio (2019 - 2026)

BioScience Health Innovations (BHIC) has 8 years of Equity Ratio data on file, last reported at 0.72 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.72, down 20.1% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.72 (down 20.1% YoY), and the FY2025 annual result was 0.87, down 9.47% from the prior year.
• Equity Ratio retreated to 0.72 in Q1 2026 per BHIC's latest filing, from 0.87 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.96 in Q4 2024 and troughed at 3.25 in Q1 2023.
• A 5-year average of 0.38 and a median of 0.83 in 2025 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2024 and 2026: Equity Ratio soared 1420.53% in 2024, then declined 20.1% in 2026.
• A 5-year view of Equity Ratio shows it stood at 0.9 in 2022, then slumped by 108.05% to 0.07 in 2023, then soared by 1420.53% to 0.96 in 2024, then fell by 9.47% to 0.87 in 2025, then retreated by 16.46% to 0.72 in 2026.
• Business Quant data shows BHIC's Equity Ratio at 0.72 in Q1 2026, 0.87 in Q4 2025, and 0.83 in Q3 2025.